Quick and Sustained Clinical Response to MEK Inhibitor I in a NF1 Patient With Neurofibromas

ecancermedicalscience - United Kingdom
doi 10.3332/ecancer.2018.862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ecancer Global Foundation

Related search

A Patient Severely Affected by Spinal Neurofibromas Carries a Recurrent Splice Site Mutation in the NF1 Gene

European Journal of Human Genetics
Genetics
2002English

P2.13-33 a Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient With NRAS Mutation Positive NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

Science
MultidisciplinaryPhilosophy of ScienceHistory
2002English

The Arg1038Gly Missense Variant in the NF1 Gene Causes a Mild Phenotype Without Neurofibromas

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

2013English

A Quick Response to Reviewer 2

2018English

Toward a Survey of Somatic Mutation of the NF1 Gene in Benign Neurofibromas of Patients With Neurofibromatosis Type 1

American Journal of Human Genetics
Genetics
2000English

Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors

Cancer Discovery
Oncology
2018English

Cotargeting MNK and MEK Kinases Induces the Regression of NF1-mutant Cancers

Journal of Clinical Investigation
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy